Switzerland · How much has NewBiologix raised?
NewBiologix has raised $50M across 1 round since 2023.
Switzerland · Series A startup
Who invested in NewBiologix
One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow NewBiologix and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$50Mraised across 1 round since 2023, from 1 source
- Latest round
- Series A, $50MMay 2023
- Investors
- 0
The rounds
- May 2023Series A$50M
No investor was named in the report.
Source recorded
Founders and team
From NewBiologix's own website: 10 on the team.
- Greg BeharChief Executive Officer of Recipharm
- Martina MolsbergenSenior Vice President Business Development
- Nicolas MermodSenior Vice President, Research & Development
- Igor FischCEO of NewBiologix
- Neil JonesChief Commercial Officer
- Tatjana BaueckerChief Financial Officer / HR
- Deborah LeySenior Director, Operations
- Florian SchmidtDirector of R&D and Program Management
- Margaux DastorBusiness Development Manager
- Tobias BonifertDirector Science & IP Strategy
Quick answers about NewBiologix
When did NewBiologix last raise?
NewBiologix's most recent round was a Series A of $50M in May 2023.
What was NewBiologix's biggest round?
Its most recent round, $50M in May 2023, is also its largest on record.
What stage is NewBiologix at?
NewBiologix's latest named round is a Series A, in May 2023.
Where is NewBiologix based?
NewBiologix is based in Switzerland.
Companies like NewBiologix
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.